In 2008, when physician leaders of large urology practices began to recognize the need for a formal association to help meet the challenges of the future, the Large Urology Group Practice Association (LUGPA) was established with the purpose of enhancing communication among large groups, allowing for benchmarking of operations, promoting quality clinical outcomes, developing new opportunities, and improving advocacy in the legislative and regulatory arenas.
USPSTF Statement by Neal D. Shore, MD, FACS, President of LUGPA
On April 11, 2017, the United States Preventive Services Task Force (USPSTF) issued an updated draft recommendation on Screening for Prostate Cancer. The following statement may be attributed to Neal D. Shore, MD, FACS, president of LUGPA:
The updated recommendation changes the grade for PSA-based screening from “D” to “C” for men aged 55-69 years. As a result, the USPSTF now recommends that clinicians discuss with men aged 55-69 what the potential benefits and harms of prostate (PSA) screening entail. For men aged 70 years and older, the USPSTF maintained its “D” recommendation that 70 and older should not be screened for prostate cancer. (more…)